Gene therapy uses safe viruses to fix or replace faulty genes, making it possible to correct the genetic cause of a disease - something that was not possible before. Although these new medicines have shown great potential, there are still some challenges. One drawback is the need for high doses, which can lead to undesirable side effects. Tavira Therapeutics, a startup launched at KU Leuven last year, is working to tackle this problem by developing an innovative technology to enhance the effectiveness of current gene therapies.
Gene therapy is helping to change the lives of individuals affected by incurable genetic conditions across the globe. ...
